Costs of First-Line Doublet Chemotherapy and Lifetime Medical Care in Advanced Non–small-Cell Lung Cancer in the United States

Ettinger, 2006, Non-small cell lung cancer. Clinical practice guidelines in oncology, J Natl Compr Canc Netw, 4, 548, 10.6004/jnccn.2006.0046

Weick, 1991, A randomized trial of five cisplatin-containing treatments in patients with metastatic non-small-cell lung cancer: a Southwest Oncology Group study, J Clin Oncol, 9, 1157, 10.1200/JCO.1991.9.7.1157

Non-small Cell Lung Cancer Collaborative Group

Schiller, 2002, Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer, N Engl J Med, 346, 92, 10.1056/NEJMoa011954

Treat, 2005, A randomized phase III trial of gemcitabine (G) in combination with carboplatin (C) or paclitaxel (P) versus paclitaxel plus carboplatin in advanced (stage IIIB, IV) non-small cell lung cancer (NSCLC): update of the alpha oncology trial (A1-99002L), J Clin Oncol, 23, 7025, 10.1200/jco.2005.23.16_suppl.lba7025

Smith, 2006, 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline, J Clin Oncol, 24, 3187, 10.1200/JCO.2006.06.4451

Hillner, 1998, Costs of care associated with non-small-cell lung cancer in a commercially insured cohort, J Clin Oncol, 16, 1420, 10.1200/JCO.1998.16.4.1420

Ramsey, 2004, Chemotherapy use, outcomes, and costs for older persons with advanced non-small-cell lung cancer: evidence from Surveillance, Epidemiology and End Results–Medicare, J Clin Oncol, 22, 4971, 10.1200/JCO.2004.05.031

US Food and Drug Administration

National Cancer Institute (NCI)

Lin, 1997, Estimating medical cost from incomplete followup data, Biometrics, 53, 419, 10.2307/2533947

Zhu, 2005, Service utilization and costs of olanzapine versus divalproex for acute mania: results from a randomized 47 week clinical trial, Curr Med Res Opin, 21, 555, 10.1185/030079905X38259

Diehr, 1999, Methods for analyzing health care utilization and costs, Annu Rev Public Health, 20, 125, 10.1146/annurev.publhealth.20.1.125

Good, 2000

Rosenbaum, 1984, Reducing bias in observational studies using subclassification on the propensity score, J Am Stat Assoc, 79, 516, 10.1080/01621459.1984.10478078

Potosky, 2004, Population variation in the initial treatment of non-small-cell lung cancer, J Clin Oncol, 22, 3261, 10.1200/JCO.2004.02.051

Cascone, 2006, Antiangiogenic drugs in non-small cell lung cancer treatment, Curr Opin Oncol, 18, 151, 10.1097/01.cco.0000208788.99570.0e

Kris, 2005, How today's developments in the treatment of non-small cell lung cancer will change tomorrow's standards of care, Oncologist, 10, S23, 10.1634/theoncologist.10-90002-23